» Articles » PMID: 33659210

A Review of Cancer Genetics and Genomics Studies in Africa

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Mar 4
PMID 33659210
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is the second leading cause of death globally and is projected to overtake infectious disease as the leading cause of mortality in Africa within the next two decades. Cancer is a group of genomic diseases that presents with intra- and inter-population unique phenotypes, with Black populations having the burden of morbidity and mortality for most types. At large, the prevention and treatment of cancers have been propelled by the understanding of the genetic make-up of the disease of mostly non-African populations. By the same token, there is a wide knowledge gap in understanding the underlying genetic causes of, and genomic alterations associated with, cancer among black Africans. Accordingly, we performed a review of the literature to survey existing studies on cancer genetics/genomics and curated findings pertaining to publications across multiple cancer types conducted on African populations. We used PubMed MeSH terms to retrieve the relevant publications from 1990 to December 2019. The metadata of these publications were extracted using R text mining packages: RISmed and Pubmed.mineR. The data showed that only 0.329% of cancer publications globally were on Africa, and only 0.016% were on cancer genetics/genomics from Africa. Although the most prevalent cancers in Africa are cancers of the breast, cervix, uterus, and prostate, publications representing breast, colorectal, liver, and blood cancers were the most frequent in our review. The most frequently reported cancer genes were , , and . Next, the genes reported in the reviewed publications' abstracts were extracted and annotated into three gene ontology classes. Genes in the class were mostly associated with , while those in and classes were mainly associated with cell process, biological regulation, and binding, and catalytic activity, respectively. Overall, this review highlights the paucity of research on cancer genomics on African populations, identified gaps, and discussed the need for concerted efforts to encourage more research on cancer genomics in Africa.

Citing Articles

Determination of the frequency and distribution of APC, PIK3CA, and SMAD4 gene mutations in Ugandan patients with colorectal cancer.

Wismayer R, Matthews R, Whalley C, Kiwanuka J, Kakembo F, Thorn S BMC Cancer. 2024; 24(1):1212.

PMID: 39350061 PMC: 11440721. DOI: 10.1186/s12885-024-12967-3.


Emerging biomarkers for non-invasive diagnosis and treatment of cancer: a systematic review.

Zakari S, Niels N, Olagunju G, Nnaji P, Ogunniyi O, Tebamifor M Front Oncol. 2024; 14:1405267.

PMID: 39132504 PMC: 11313249. DOI: 10.3389/fonc.2024.1405267.


The future of collaborative precision oncology approaches in sub-Saharan Africa: learnings from around the globe.

Gueye A, Maroun B, Zimur A, Berkovits T, Tan S Front Oncol. 2024; 14:1426558.

PMID: 38974239 PMC: 11224929. DOI: 10.3389/fonc.2024.1426558.


Building genomic capacity for precision health in Africa.

Olono A, Mitesser V, Happi A, Happi C Nat Med. 2024; 30(7):1856-1864.

PMID: 38961224 DOI: 10.1038/s41591-024-03081-9.


Exploring prostate cancer screening among men in Accra using the health belief model.

Boafo I, Tetteh P, Hiadzi R Ghana Med J. 2024; 57(3):226-233.

PMID: 38957671 PMC: 11216731. DOI: 10.4314/gmj.v57i3.10.


References
1.
Mabrouk I, Baccouche S, El-Abed R, Mokdad-Gargouri R, Mosbah A, Said S . No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann N Y Acad Sci. 2004; 1010:764-70. DOI: 10.1196/annals.1299.137. View

2.
Mohammed A, Kamel A, Hammad S, Afifi H, El Sanabary Z, El Din M . Constitutional retinoblastoma gene deletion in Egyptian patients. World J Pediatr. 2009; 5(3):222-5. DOI: 10.1007/s12519-009-0042-1. View

3.
Bougatef K, Marrakchi R, Kourda N, Ben Lahely Y, Jileni S, El Khil H . Somatic mutation of MutYH in Tunisian patients with sporadic colorectal cancer. J Clin Lab Anal. 2007; 21(6):372-4. PMC: 6649000. DOI: 10.1002/jcla.20198. View

4.
Elimam A, Aabdein M, Eldeen M, Altayb H, Taha M, Nimir M . Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer. BMC Med Genet. 2017; 18(1):85. PMC: 5559773. DOI: 10.1186/s12881-017-0448-x. View

5.
Lawson J, Salmons B, Glenn W . Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV). Front Oncol. 2018; 8:1. PMC: 5786831. DOI: 10.3389/fonc.2018.00001. View